AbCellera Biologics Inc.

ABCL · Healthcare

$11.28

Capitalización: 3.66B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar AbCellera Biologics Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Business Wire2 sept 2026, 20:05

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

Business Wire31 ago 2026, 16:03

BostonGene to Showcase Novel Genomic Classifier and Immunotherapy Selection Framework at SOHO 2026

Insider Monkey16 ago 2026, 1:09

AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity

Insider Monkey14 ago 2026, 22:53

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

MT Newswires13 ago 2026, 8:15

AbCellera Biologics Prices $200 Million Offering of Shares, Pre-Funded Warrants